Company Filing History:
6 out of 4,443 
1 out of 832,812 Years Active: 1994-1996
Title: The Innovations of Craig S Hoechstetter
Introduction
Craig S Hoechstetter is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with serotonin receptors. With a total of 7 patents to his name, Hoechstetter's work has implications for various therapeutic applications.
Latest Patents
Among his latest patents are the novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes. These compounds exhibit binding activity at the serotonin 1A receptor, which is crucial for various neurological functions. Another significant patent involves ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes, including their corresponding sulfoxides and sulfones. These compounds also demonstrate agonist activity at the serotonin 1A receptor, showcasing Hoechstetter's innovative approach to drug design.
Career Highlights
Throughout his career, Craig S Hoechstetter has worked with prominent companies, including Eli Lilly and Company. His experience in the pharmaceutical industry has allowed him to develop groundbreaking inventions that contribute to advancements in medicine.
Collaborations
Hoechstetter has collaborated with notable colleagues such as John M Schaus and Diane L Huser. These partnerships have fostered a creative environment that has led to the successful development of his patented inventions.
Conclusion
Craig S Hoechstetter's contributions to the field of pharmaceuticals through his innovative patents highlight his expertise and dedication to advancing medical science. His work continues to influence the development of new therapeutic agents.